Editas Medicine
EDIT
$5.47
Share price
4.99%
Change (1 day)
-34.10%
Change (1 year)
Editas Medicine (EDIT) - Cash on Hand
Cash on Hand as of December 2023 : $0.32 B
According to Editas Medicine
's latest financial reports the company has $0.32 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Editas Medicine - Cash on Hand chart (from 2014 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.32 B | -6.15% |
| 2022-12-31 | $0.34 B | -31.12% |
| 2021-12-31 | $0.49 B | 24.31% |
| 2020-12-31 | $0.40 B | -12.04% |
| 2019-12-31 | $0.45 B | 23.9% |
| 2018-12-31 | $0.36 B | 12.1% |
| 2017-12-31 | $0.32 B | 77.6% |
| 2016-12-31 | $0.18 B | 29.43% |
| 2015-12-31 | $0.14 B | 1247.83% |
| 2014-12-31 | $10.62 M | 427.98% |
| 2013-12-31 | $2.01 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $5.29 M | -98.36% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | -61.19% | 🇬🇧 UK |
 Novavax NVAX | $0.56 B | 75.95% | 🇺🇸 USA |
 Novocure
NVCR | $0.91 B | 181.83% | Jersey |